Alto Neuroscience (NYSE:ANRO) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report released on Thursday morning,Benzinga reports. HC Wainwright currently has a $10.00 target price on the stock. A number of other equities analysts also recently weighed in on the stock. William Blair reissued an “outperform” rating on shares […]
